Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt?

Eur Respir J. 2004 Dec;24(6):1025-32. doi: 10.1183/09031936.04.00092004.

Abstract

In 2003, the onset of severe acute respiratory syndrome (SARS) caused worldwide chaos. Although SARS was eradicated by isolation towards the end of 2003, sporadic cases have been reported in Singapore, Taiwan and mainland China. In this review, SARS is discussed as a disease, as well as its diagnosis, management and pharmacotherapy. Respiratory physicians and healthcare professionals have to be aware of advances in the understanding of the diagnosis and management of severe acute respiratory syndrome. More research is required in order to prepare for if this respiratory infection recurs, but there are concerns that adequate pharmaceutical support may be lacking for the development of a vaccine.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • China / epidemiology
  • Communicable Disease Control
  • Communicable Diseases, Emerging / diagnosis*
  • Communicable Diseases, Emerging / drug therapy*
  • Communicable Diseases, Emerging / epidemiology
  • Diagnosis, Differential
  • Disease Outbreaks
  • Humans
  • Immunotherapy / methods
  • Radiography, Thoracic
  • Severe Acute Respiratory Syndrome / diagnosis*
  • Severe Acute Respiratory Syndrome / drug therapy*
  • Severe Acute Respiratory Syndrome / epidemiology
  • Taiwan / epidemiology

Substances

  • Anti-Bacterial Agents
  • Antiviral Agents